Development and validation of a claims-based measure as an indicator for disease status in patients with multiple sclerosis treated with disease-modifying drugs

Overview of attention for article published in BMC Neurology, June 2017

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 9 Dimensions

Readers on

mendeley: 74 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 9 publications that cite this research output.

9

The most recent citing publications are shown below. View all 9 publications that cite this research output on Dimensions.

A comparison of clinical, utilization, and cost outcomes between oral treatments for multiple sclerosis.

Article in Journal of Managed Care & Specialty Pharmacy (February 2024)

Claims-based algorithm to estimate the Expanded Disability Status Scale for multiple sclerosis in a German health insurance fund: a validation study using patient medical records

Article in Frontiers in Neurology (December 2023)

Cost associated with a relapse-free patient in multiple sclerosis: A real-world health indicator

Article in PLOS ONE (April 2022)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.